Patents by Inventor Mark Cutler

Mark Cutler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10078040
    Abstract: A flexibility testing apparatus for wire or cable. Two circular, rotatable gears are mounted to a frame, one gear being a drive gear and the other being a driven gear. The driven gear is coplanar with the drive gear and the drive gear teeth are enmeshed with the driven gear teeth. Two rods are connected to the mounting holes of the drive gear and the wire or cable is attached to the rods using barrel end clamps for flexing. The driven gear can be rotated at different speeds by an electric motor or a pneumatic driving device.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: September 18, 2018
    Assignee: CHAMPLAIN CABLE CORP.
    Inventors: Futsum G. Woldesus, Douglas Mark Cutler
  • Publication number: 20180024033
    Abstract: A flexibility testing apparatus for wire or cable. Two circular, rotatable gears are mounted to a frame, one gear being a drive gear and the other being a driven gear. The driven gear is coplanar with the drive gear and the drive gear teeth are enmeshed with the driven gear teeth. Two rods are connected to the mounting holes of the drive gear and the wire or cable is attached to the rods using barrel end clamps for flexing. The driven gear can be rotated at different speeds by an electric motor or a pneumatic driving device.
    Type: Application
    Filed: July 20, 2016
    Publication date: January 25, 2018
    Applicant: Champlain Cable Corporation
    Inventors: Futsum G. Woldesus, Douglas Mark Cutler
  • Patent number: 7687240
    Abstract: A process for producing isolated and purified respiratory syncytial virus (RSV) fusion (F) and attachment (G) glycoproteins in eukaryotic cell cultures infected with RSV cold-passaged, temperature-sensitive mutant subgroup A2 strain cpts-248/404 results in at least a 5-fold increase in F and G protein yields when compared with the parent A2 strain. Immunogenic compositions comprising the F and/or G protein(s) produced by this process can be formulated for in vivo administration to a host to confer protection against disease caused by RSV.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: March 30, 2010
    Assignee: Wyeth Holdings Corporation
    Inventors: Firelli Alonso-Caplen, Mark Cutler, Mirelli Fino, Earl Pursell, Robert Repetto
  • Publication number: 20060171955
    Abstract: A process for producing isolated and purified respiratory syncytial virus (RSV) fusion (F) and attachment (G) glycoproteins in eukaryotic cell cultures infected with RSV cold-passaged, temperature-sensitive mutant subgroup A2 strain cpts-248/404 results in at least a 5-fold increase in F and G protein yields when compared with the parent A2 strain. Immunogenic compositions comprising the F and/or G protein(s) produced by this process can be formulated for in vivo administration to a host to confer protection against disease caused by RSV.
    Type: Application
    Filed: March 17, 2004
    Publication date: August 3, 2006
    Inventors: Firelli Alonso-Caplen, Mark Cutler, Mirelli Fino, Earl Pursell, Robert Repetto